Variant report

Variant	rs11914549
Chromosome Location	chr3:50408855-50408856
allele	A/G
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

No.	Distal block	Cell Line	Cell type
1	chr3:50401635..50404173-chr3:50408002..50409529,2	MCF-7	breast:
2	chr3:50407190..50409972-chr3:50577719..50580221,2	K562	blood:
3	chr3:50407737..50410112-chr3:50424315..50425913,2	K562	blood:
4	chr3:50407329..50410054-chr3:50589199..50591435,2	K562	blood:

Variant related genes	Relation type
ENSG00000007402	Chromatin interaction
ENSG00000271858	Chromatin interaction

Extended variants
information (count: 59 )
Associated
traits (count: 0)

rSNPs within LD-proxies of this variant (count:41)

rs_ID	r²[population]
rs1034408	0.81[AFR][1000 genomes]
rs28593422	0.82[AFR][1000 genomes]
rs35742391	0.89[AMR][1000 genomes];0.82[EUR][1000 genomes]
rs41305886	0.88[AFR][1000 genomes]
rs4422301	0.89[AFR][1000 genomes]
rs55876418	0.91[AFR][1000 genomes]
rs56114301	0.81[AFR][1000 genomes]
rs56249615	0.81[AFR][1000 genomes]
rs56258146	0.81[AFR][1000 genomes]
rs56287038	0.93[AFR][1000 genomes];1.00[AMR][1000 genomes];1.00[EUR][1000 genomes]
rs57405128	0.91[AFR][1000 genomes]
rs57415469	0.81[AFR][1000 genomes]
rs57453427	0.84[AMR][1000 genomes];0.82[EUR][1000 genomes]
rs58415636	0.95[AFR][1000 genomes];1.00[AMR][1000 genomes];1.00[EUR][1000 genomes]
rs59012751	0.81[AFR][1000 genomes]
rs59790001	0.89[AFR][1000 genomes]
rs60273100	0.81[AFR][1000 genomes]
rs61382127	1.00[EUR][1000 genomes]
rs6446203	0.96[AFR][1000 genomes];1.00[AMR][1000 genomes];1.00[EUR][1000 genomes]
rs6768830	0.84[AMR][1000 genomes];0.82[EUR][1000 genomes]
rs6770258	0.91[AFR][1000 genomes]
rs6770669	0.91[AFR][1000 genomes]
rs73832879	0.81[AFR][1000 genomes]
rs73832881	0.82[AFR][1000 genomes]
rs73833366	0.82[AFR][1000 genomes]
rs73833371	0.81[AFR][1000 genomes]
rs73833373	0.89[AFR][1000 genomes]
rs73833386	0.81[AFR][1000 genomes]
rs743755	0.82[AFR][1000 genomes]
rs7610830	0.89[AFR][1000 genomes]
rs7612820	0.81[AFR][1000 genomes]
rs7617345	0.93[AFR][1000 genomes]
rs7625295	0.81[AFR][1000 genomes]
rs7629917	0.83[AFR][1000 genomes];0.84[AMR][1000 genomes];1.00[EUR][1000 genomes]
rs7634307	0.81[AFR][1000 genomes]
rs7640842	0.82[AFR][1000 genomes]
rs7641224	0.82[EUR][1000 genomes]
rs886075	0.89[AMR][1000 genomes];0.82[EUR][1000 genomes]
rs9851719	0.82[EUR][1000 genomes]
rs9875873	0.82[EUR][1000 genomes]
rs9878345	0.82[EUR][1000 genomes]

Variant overlapped rSNPs/rCNVs (count:18 , 50 per page) page: 1

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	nsv523662	chr3:50144951-50584999	Flanking Bivalent TSS/Enh Weak transcription Genic enhancers Bivalent Enhancer Strong transcription Transcr. at gene 5' and 3' Flanking Active TSS Enhancers Active TSS Bivalent/Poised TSS ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	101 gene(s)	inside rSNPs	diseases
2	esv1821728	chr3:50156142-50657253	Strong transcription Weak transcription Flanking Active TSS Active TSS Bivalent Enhancer Transcr. at gene 5' and 3' Enhancers Genic enhancers Bivalent/Poised TSS Flanking Bivalent TSS/Enh ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	109 gene(s)	inside rSNPs	diseases
3	esv1793751	chr3:50157364-50476363	Weak transcription Enhancers Transcr. at gene 5' and 3' Strong transcription Flanking Bivalent TSS/Enh Genic enhancers Flanking Active TSS Active TSS Bivalent Enhancer Bivalent/Poised TSS ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	98 gene(s)	inside rSNPs	diseases
4	esv1828162	chr3:50157364-50506151	Enhancers Genic enhancers Transcr. at gene 5' and 3' Flanking Active TSS Active TSS Weak transcription Strong transcription Bivalent Enhancer Bivalent/Poised TSS Flanking Bivalent TSS/Enh ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	98 gene(s)	inside rSNPs	diseases
5	nsv470561	chr3:50158774-50584999	Flanking Active TSS Enhancers Weak transcription Genic enhancers Active TSS Bivalent Enhancer Strong transcription Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3' Bivalent/Poised TSS ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	99 gene(s)	inside rSNPs	diseases
6	nsv876770	chr3:50158774-50609624	Active TSS Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer Strong transcription Genic enhancers Transcr. at gene 5' and 3' Bivalent/Poised TSS ZNF genes & repeats Flanking Bivalent TSS/Enh	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	103 gene(s)	inside rSNPs	diseases
7	nsv1001993	chr3:50187646-50640808	Weak transcription Enhancers Flanking Active TSS Active TSS Genic enhancers Bivalent/Poised TSS Bivalent Enhancer Strong transcription Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3' ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	104 gene(s)	inside rSNPs	diseases
8	nsv460531	chr3:50247824-50436827	Strong transcription Bivalent/Poised TSS Enhancers Flanking Active TSS Genic enhancers Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3' Weak transcription Active TSS Bivalent Enhancer ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	93 gene(s)	inside rSNPs	diseases
9	nsv590255	chr3:50247824-50436827	Weak transcription Flanking Active TSS Strong transcription Enhancers Active TSS Bivalent Enhancer Transcr. at gene 5' and 3' Genic enhancers Bivalent/Poised TSS Flanking Bivalent TSS/Enh ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	93 gene(s)	inside rSNPs	diseases
10	nsv876772	chr3:50255305-50436827	Weak transcription Flanking Active TSS Strong transcription Enhancers Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Genic enhancers Bivalent/Poised TSS ZNF genes & repeats Transcr. at gene 5' and 3'	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	93 gene(s)	inside rSNPs	diseases
11	nsv590256	chr3:50302830-50420554	Weak transcription Enhancers Active TSS Strong transcription Flanking Active TSS Genic enhancers Transcr. at gene 5' and 3' Bivalent Enhancer Flanking Bivalent TSS/Enh Bivalent/Poised TSS ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	83 gene(s)	inside rSNPs	diseases
12	nsv876774	chr3:50302830-50436827	Enhancers Strong transcription Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh Weak transcription Genic enhancers Transcr. at gene 5' and 3' Bivalent Enhancer Bivalent/Poised TSS ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	83 gene(s)	inside rSNPs	diseases
13	nsv876773	chr3:50302830-50480131	Active TSS Bivalent/Poised TSS Transcr. at gene 5' and 3' Genic enhancers Enhancers Weak transcription Strong transcription Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	87 gene(s)	inside rSNPs	diseases
14	nsv834693	chr3:50302830-50507964	Enhancers Weak transcription Flanking Bivalent TSS/Enh Active TSS Flanking Active TSS Strong transcription Bivalent Enhancer Bivalent/Poised TSS Transcr. at gene 5' and 3' Genic enhancers ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	87 gene(s)	inside rSNPs	diseases
15	nsv876775	chr3:50324672-50504896	Flanking Active TSS Weak transcription Enhancers Strong transcription Flanking Bivalent TSS/Enh Genic enhancers Active TSS Transcr. at gene 5' and 3' Bivalent Enhancer Bivalent/Poised TSS ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	82 gene(s)	inside rSNPs	diseases
16	esv3584502	chr3:50368278-50659741	Strong transcription Bivalent/Poised TSS Enhancers Weak transcription Flanking Active TSS Active TSS Genic enhancers Transcr. at gene 5' and 3' Bivalent Enhancer Flanking Bivalent TSS/Enh ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	55 gene(s)	inside rSNPs	diseases
17	nsv432419	chr3:50388396-50637496	Weak transcription Enhancers Flanking Active TSS Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3' Bivalent Enhancer Active TSS Genic enhancers Strong transcription Bivalent/Poised TSS ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	32 gene(s)	inside rSNPs	diseases
18	nsv590259	chr3:50408398-50411819	Weak transcription Enhancers Bivalent Enhancer Strong transcription Active TSS Flanking Active TSS	Chromatin interactive region	5 gene(s)	inside rSNPs	diseases

No data

Chromatin state (count:50 , 50 per page) page: 1

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr3:50403200-50417200	Weak transcription	Pancreatic Islets	Pancreatic Islet
2	chr3:50403400-50410000	Weak transcription	Brain Cingulate Gyrus	brain
3	chr3:50403800-50409600	Weak transcription	Primary hematopoietic stem cells	blood
4	chr3:50403800-50409600	Weak transcription	Fetal Intestine Small	intestine
5	chr3:50403800-50409800	Weak transcription	Primary hematopoietic stem cells G-CSF-mobilized Female	--
6	chr3:50403800-50409800	Weak transcription	Primary hematopoietic stem cells G-CSF-mobilized Male	--
7	chr3:50403800-50410000	Weak transcription	iPS-15b Cell Line	embryonic stem cell
8	chr3:50404000-50409400	Weak transcription	Fetal Thymus	thymus
9	chr3:50404000-50409800	Weak transcription	Thymus	Thymus
10	chr3:50404200-50410600	Weak transcription	Primary T cells effector/memory enriched fromperipheralblood	blood
11	chr3:50404600-50409800	Weak transcription	Primary T killer naive cells fromperipheralblood	blood
12	chr3:50404600-50410000	Weak transcription	Primary mononuclear cells fromperipheralblood	Blood
13	chr3:50404600-50415400	Weak transcription	Primary Natural Killer cells fromperipheralblood	blood
14	chr3:50405000-50409800	Weak transcription	Primary T cells from cord blood	blood
15	chr3:50405000-50416400	Weak transcription	Gastric	stomach
16	chr3:50405200-50409800	Weak transcription	Primary T helper cells PMA-I stimulated	--
17	chr3:50405600-50409800	Weak transcription	Primary T helper naive cells fromperipheralblood	blood
18	chr3:50405600-50410000	Weak transcription	Primary T helper cells fromperipheralblood	blood
19	chr3:50405800-50411200	Weak transcription	Breast Myoepithelial Primary Cells	Breast
20	chr3:50406000-50411000	Enhancers	iPS DF 19.11 Cell Line	embryonic stem cell
21	chr3:50406800-50409800	Weak transcription	Spleen	Spleen
22	chr3:50407200-50410600	Enhancers	ES-UCSF4 Cell Line	embryonic stem cell
23	chr3:50407400-50409600	Bivalent Enhancer	Fetal Muscle Trunk	muscle
24	chr3:50407400-50413400	Enhancers	Brain Germinal Matrix	brain
25	chr3:50407600-50411000	Enhancers	Fetal Muscle Leg	muscle
26	chr3:50408000-50409200	Enhancers	Brain Angular Gyrus	brain
27	chr3:50408000-50409200	Enhancers	Brain Inferior Temporal Lobe	brain
28	chr3:50408000-50409200	Enhancers	Fetal Brain Male	brain
29	chr3:50408000-50410200	Enhancers	K562	blood
30	chr3:50408200-50410800	Enhancers	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
31	chr3:50408200-50411000	Enhancers	hESC Derived CD56+ Ectoderm Cultured Cells	ES cell derived
32	chr3:50408200-50411000	Enhancers	HUES6 Cell Line	embryonic stem cell
33	chr3:50408400-50409000	Enhancers	Brain Dorsolateral Prefrontal Cortex	brain
34	chr3:50408400-50409000	Enhancers	Fetal Lung	lung
35	chr3:50408400-50409400	Weak transcription	A549	lung
36	chr3:50408400-50410800	Enhancers	H1 Cell Line	embryonic stem cell
37	chr3:50408400-50411400	Enhancers	Fetal Stomach	stomach
38	chr3:50408400-50413200	Enhancers	H1 Derived Neuronal Progenitor Cultured Cells	ES cell derived
39	chr3:50408600-50409000	Bivalent Enhancer	H1 Derived Mesenchymal Stem Cells	ES cell derived
40	chr3:50408600-50409000	Bivalent Enhancer	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
41	chr3:50408600-50413000	Enhancers	H9 Derived Neuron Cultured Cells	ES cell derived
42	chr3:50408800-50409400	Weak transcription	Primary hematopoietic stem cells short term culture	blood
43	chr3:50408800-50410000	Weak transcription	iPS DF 6.9 Cell Line	embryonic stem cell
44	chr3:50408800-50410000	Weak transcription	Ganglion Eminence derived primary cultured neurospheres	brain
45	chr3:50408800-50410200	Weak transcription	HUES64 Cell Line	embryonic stem cell
46	chr3:50408800-50410400	Weak transcription	HUES48 Cell Line	embryonic stem cell
47	chr3:50408800-50411000	Enhancers	Fetal Adrenal Gland	Adrenal Gland
48	chr3:50408800-50412000	Weak transcription	Lung	lung
49	chr3:50408800-50413000	Enhancers	H9 Derived Neuronal Progenitor Cultured Cells	ES cell derived
50	chr3:50408800-50423800	Weak transcription	Fetal Brain Female	brain

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links